CME LLC

About this Activity
This program will provide clinicians with a thorough understanding of the importance of diagnosis of BPD and effective management.

Learning Objectives
By participating in this symposium, learners will be able to:

• Outline the importance of proper diagnosis in bipolar disorder and the ramifications of misdiagnosed bipolar disorder
  
• Describe the growing research in the genetics and neurobiology of BD and their possible treatment implications
  
• Compare and contrast the efficacy and safety of current treatment options used in the management of BD

Who Will Benefit
This activity was designed to meet the continuing education needs of psychiatrists and other physicians. Other mental health professionals may find this activity informative and should check with their state licensing and certification boards to determine if it meets their continuing education requirements.

Your Distinguished Faculty

	Caleb M. Adler, MD Associate Professor of Clinical Psychiatry and Neuroscience; Co-Director, Division of Bipolar Disorders Research; Assistant Director, Center for Imaging Research, University of Cincinnati College of Medicine
	Terence A. Ketter, MD Professor of Psychiatry and Behavioral Sciences; Chief, Bipolar Disorders Clinic, Stanford

Faculty Disclosures
Caleb M. Adler, MD, is a member of the Speakers Bureau, serves as a consultant for, and receives honoraria/research support from, AstraZeneca. He receives grants/research support from Martek Biosciences Corporation, Abbott Laboratories, Eli Lilly and Company, Johnson & Johnson, Shire, Janssen, Bristol-Myers Squibb Company, Repligen, Pfizer, and Somerset.

Terence A. Ketter, MD, is a consultant for, has received honoraria, and grant/reserach support from Abbott Laboratories, Inc., AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutica Products, LP, Novartis Pharmaceuticals Corporation, Pfizer Inc., and Shire Pharmaceuticals Group plc. He has also received grant/research support from and serves as a consultant for Repligen Corporation, Elan Pharmaceuticals, Inc., Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, and serves as a consultant for Cephalon Inc., Corcept Therapeutics, Forest Laboratories, Inc., Jazz Pharmaceuticals, Inc., Merck & Co., Inc., and UCB Pharmaceuticals. Dr. Ketter has also received grant/research support from Eisai Inc., and has received honoraria from Johnson & Johnson. His spouse is also employed by Johnson & Johnson.

Commercial Support

Supported by an educational grant from Eli Lilly and Company

Disclaimers
The content of this video activity may include product information that is inconsistent with or outside of the approved labeling for these products in the United States. Before prescribing any medication, you must familiarize yourself with the manufacturer's product information.

To earn continuing education credit, view this online course and complete the posttest and evaluation provided. A passing score of 75% or more must be achieved on the posttest. A link is provided within this online activity to access the posttest and evaluation. You will have the option of printing a CME Certificate for your records after submission of the evaluation.

CME LLC and are not responsible for the speaker's statements, materials, acts or omissions.

Continuing Medical Education
CME LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME LLC designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Content Originally Presented: 10/31/08; 7:15-9:15pm
Online Date: 12/20/08
Credit Expiration Date: 12/20/09

This activity is based on the symposium The Importance of Diagnosis of BPD and Effective Management on October 30, 2008 in San Diego, CA and may not reflect the most current information. Participants who attended the live symposium mentioned above cannot claim credit for this activity.